Increase in T‐Cells Bearing CD25 in Bronchoalveolar Lavage Fluid from HAM/TSP Patients and HTLV‐I Carriers
Open Access
- 1 January 1994
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 38 (1) , 55-62
Abstract
To determine the immunologic characteristics of T‐cells in local pulmonary lesions of human T‐cell lymphotropic virus type I (HTLV‐I) carriers, we investigated lymphocyte surface markers in peripheral blood and bronchoalveolar lavage fluid (BALF) of 38 HTLV‐I carriers, 8 HTLV‐I associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 44 HTLV‐I seronegative patients with pulmonary diseases and 7 healthy volunteers using two‐color flow cytometric analysis. In peripheral blood, activated T‐cells, CD4+HLA‐DR +, CD8 + HLA‐DR + and CD3 + CD25 +, and CD4+CD29+ cells increased significantly in carriers and HAM/TSP patients compared with healthy volunteers and seronegative patients. In BALF, T‐cells, especially CD25+ cells, increased significantly in carriers and HAM/TSP patients, compared with healthy volunteers and seronegative patients. These findings indicated that T‐cells in the lungs, as well as in peripheral blood, are activated in carriers and HAM/TSP patients. Interestingly, there was dissociation between expression of CD3 + CD25+ cells in BALF and peripheral blood from these patients. These results suggest that T‐cells activated probably by HTLV‐I accumulate in the lungs in some carriers and HAM/TSP patients, and HTLV‐I may be involved in the immunologic dysfunction in the lungs of these patients. However, we did not find any correlation between the degree of clinical features and the elevation of CD3 + CD25+ cells in BALF, or its characteristic features on chest roentgenograms.Keywords
This publication has 32 references indexed in Scilit:
- Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluid.Thorax, 1990
- Activated t‐lymphocytes with polyclonal gammopathy in patients with human t‐lymphotropic virus type i—associated myelopathyAnnals of Neurology, 1988
- Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesisAnnals of Neurology, 1988
- Flow Cytometric Analysis of Lymphocyte Subsets in the Bronchoalveolar Lavage Fluid and Peripheral Blood of Healthy VolunteersScandinavian Journal of Immunology, 1986
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- The pX Protein of HTLV-I Is a Transcriptional Activator of Its Long Terminal RepeatsScience, 1985
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985
- Trans -Acting Transcriptional Activation of the Long Terminal Repeat of Human T Lymphotropic Viruses in Infected CellsScience, 1984
- Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.Journal of Experimental Medicine, 1983
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980